65,437 trials
Recurrent Uterine Corpus Sarcoma · Uterine Corpus Leiomyosarcoma
Primary: Progression-free Survival (PFS) > 6 Months — 0.0 percentage of participants
Insomnia · Schizophrenia · Schizoaffective Disorder
Primary: Change in Insomnia Severity Index From Baseline. — -10.7; -6.9 units on a scale — p=0.039
Hormone-Resistant Prostate Cancer · Metastatic Malignant Neoplasm in the Bone · Recurrent Prostate Carcinoma
Primary: Changes in 18F-fluoride PET (SUV) - Tumor Bone — -6.67 SUVmax — p=<0.001
Infra-orbital Skin Depressions
Primary: Percentage of Subjects With a ≥1 Grade Improvement From Baseline in Infra-Orbital Area on the Allergan Infra-Orbital Rating Scale (AIRS) on the Right and Left Side — 99…
Pulmonary Disease, Chronic Obstructive
Primary: Forced Expiratory Volume in One Second (FEV1) Area Under the Curve (AUC) (0-3h) Response on Day 169. — 0.133; 0.148; 0.139; 0.241 Litres — p=<0.0001
Interstitial Cystitis
Primary: O'Leary-Santa Interstitial Cystitis Symptom Index and Problem Index (OSPI) Score — 27.7; 27.8; 19.6; 19.9 units on a scale — p=0.75
Pulmonary Disease, Chronic Obstructive
Primary: Forced Expiratory Volume in One Second (FEV1) Area Under the Curve (AUC) (0-3h) Response on Day 169 — 0.136; 0.125; 0.165; 0.256 Litres — p=<0.0001
Pulmonary Disease, Chronic Obstructive
Primary: Forced Expiratory Volume in 1 Second (FEV1) AUC0-24h Response [L] After 6 Weeks Treatment. — -0.037; 0.129; 0.117; 0.133 Litres (L) — p=<0.0001
Tooth Loss
Primary: The Implant Survival — 97.6 percentage of participants
Lymphoma · Small Intestine Cancer
Primary: Safety and Tolerability of Vorinostat (SAHA) After Autologous Stem Cell Transplantation — 12; 11; 11; 10 patients
Healthy
Primary: AUC0-168 (Area Under the Concentration-time Curve of Clonidine in Plasma Over the Time Interval From 0 to 168 h) — 82517.99; 80641.47 pg*h/mL — p=<0.0001
Aphasia
Primary: Speech Production — 5.27; 5.28 % change score of untrained real words
Cystic Fibrosis
Primary: Medication Adherence — 91.6; 100 Percent Adherence
Hypoparathyroidism
Primary: Requirements for Calcium Supplementation — 3.03; 1.66 grams per day of calcium supplementation
Pulmonary Disease, Chronic Obstructive
Primary: Forced Expiratory Volume in One Second (FEV1) Area Under the Curve (AUC) (0-3hours) Response After Single-dose Administration — 0.014; 0.233; 0.266 Litres — p=<0.0001